跳至主要内容
临床试验/NCT05762198
NCT05762198已完成不适用

A Randomized Controlled Trial Comparing Water Vapour Thermal Therapy (Rezūm) and TURP in Men With Benign Prostatic Hyperplasia in Refractory Urinary Retention

Chinese University of Hong Kong2 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2023年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
108
试验地点
2
主要终点
Changes in International Prostate Symptom Score (IPSS) at 12 months after treatment

研究概览

简要总结

This is a randomized controlled trial using a non-inferiority design with the subjects randomized 1:1 to either water vapour thermal treatment (REZUM) arm or transurethral resection of prostate (TURP) arm.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Men 50-80 years
  • Refractory urinary retention related to benign prostatic hyperplasia (BPH)
  • On urethral Foley's catheter before treatment
  • Prostate size 30-80ml on ultrasound

排除标准

  • Prior prostate operation
  • Past or current history of prostate cancer
  • Strong suspicion of prostate cancer (e.g. Elevated PSA before urinary retention or abnormal prostate on DRE without workup for prostate cancer)
  • Known Urethral stricture / Bladder stone / Hypocontractile bladder
  • Known neurological diseases which may affect bladder function (e.g. Parkinsonism, stroke)
  • Contraindicated to undergo TURP or REZUM (e.g. not fit for GA/SA, active urinary tract infection, fail to be placed in lithotomy position, uncorrectable coagulopathy, antiplatelet or anticoagulant which cannot be stopped)

研究组 & 干预措施

Rezūm

Active Comparator

干预措施: Rezūm (Device)

TURP

Active Comparator

干预措施: TURP (Device)

结局指标

主要结局

Changes in International Prostate Symptom Score (IPSS) at 12 months after treatment

时间窗: Baseline, 3 months, 6 months and 12 months after intervention

IPSS score ranging from 0-35 (the higher the worse)

次要结局

  • Complication rate(30 days after intervention)
  • Successful trial without catheter (TWOC) within 3 months(At 3 months)
  • Post-op quality of life score(Baseline, 3 months, 6 months and 12 months after intervention)
  • Unplanned readmission rate after operation in 30 days(30 days after intervention)
  • Change in voiding function in uroflowmetry(Baseline, 3 months, 6 months and 12 months after intervention)
  • Post-op International Index of Erectile function score(Baseline, 3 months, 6 months and 12 months after intervention)
  • Hospital stays of procedure(On Discharge)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

CHIU Ka Fung Peter

Professor

Chinese University of Hong Kong

研究点 (2)

Loading locations...

相似试验

已完成
不适用
A randomized controlled trial for the comparison of the bleeding during hepatectomy with and without clamping the inferior vena cava below the liver.The patient who need open hepatectomy.
JPRN-UMIN000003317Yokohama city university graduate school of medicine200
已完成
不适用
A randomized controlled trial for the comparison of the benefit of preoperative supplementation of a branched chain amino acid (BCAA) granules for patients undergoing liver resection for hepatocellular carcinoma.Hepatocellular carcinoma
JPRN-UMIN000004244Yokohama city university graduate school of medicine80
已完成
3 期
A randomized controlled trial for the comparison of radiofrequency ablation with and without transcatheter arterial chemoembolization for patients with hepatocellular carcinomahepatocellular carcinoma
JPRN-UMIN000002083Yokohama City University Medical Center Gastroenterological Center40
招募中
1 期
Personalized dosing of immunosuppression after kidney transplantation by measuring the immune system functionalityPost Kidney transplantationMedDRA version: 21.1Level: LLTClassification code: 10050436Term: Prophylaxis against renal transplant rejection Class: 10042613
CTIS2022-500024-30-00Medical University Of Vienna260
招募中
不适用
The utility of bile duct stent placement in liver transplantatioBiliary complicationsliver transplantSurgery - Surgical techniquesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
ACTRN12619000776101Princess Alexandra Hospital80